{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T13:56:28Z","timestamp":1778162188696,"version":"3.51.4"},"reference-count":41,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,9,1]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>Euglycaemic diabetic ketoacidosis is a serious but rare adverse effect of treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors. A man in his 60s with type 2 diabetes mellitus underwent total hip replacement for an intracapsular neck of femur fracture. His SGLT-2 inhibitor was continued perioperatively and blood glucose levels were normal throughout the admission. A diagnosis of severe euglycaemic diabetic ketoacidosis was made in the operating theatre which required treatment in a critical care unit. This resulted in increased morbidity due to decreased postoperative mobilisation and a new requirement for subcutaneous insulin. This case highlights the need for withholding SGLT-2 inhibitors in patients admitted for emergency surgery and a need for regular ketone monitoring in these patients, even in the context of normoglycaemia.<\/jats:p>","DOI":"10.1136\/bcr-2022-250233","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T13:12:20Z","timestamp":1663333940000},"page":"e250233","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["SGLT-2 inhibitor associated euglycaemic diabetic ketoacidosis in an orthopaedic trauma patient"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0751-1391","authenticated-orcid":false,"given":"Duncan Taylor","family":"Ritchie","sequence":"first","affiliation":[{"name":"Department of Trauma and Orthopaedic Surgery, NHS Grampian, Aberdeen, UK"},{"name":"School of Medicine Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Dixon","sequence":"additional","affiliation":[{"name":"Department of Trauma and Orthopaedic Surgery, NHS Grampian, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"2025082801214667000_15.9.e250233.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1583"},{"key":"2025082801214667000_15.9.e250233.2","unstructured":"Joint British Diabetes Societies for Inpatient Care . The management of diabetic ketoacidosis in adults., 2021. Available: https:\/\/abcd.care\/sites\/abcd.care\/files\/site_uploads\/JBDS_02%20_DKA_Guideline_amended_v2_June_2021.pdf [Accessed 18 Oct 2021]."},{"key":"2025082801214667000_15.9.e250233.3","unstructured":"Yaqoob MM , Water MK . electrolytes and acid-base balance. In: Clark M , ed, 2017: 178\u20139."},{"key":"2025082801214667000_15.9.e250233.4","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12401"},{"key":"2025082801214667000_15.9.e250233.5","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2886","article-title":"Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: basic mechanisms and therapeutic perspectives","volume":"33","author":"Qiu","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"2025082801214667000_15.9.e250233.6","unstructured":"Medicines and Healthcare products Regulatory Agency . Sglt2 inhibitors: updated advice on the risk of diabetic ketoacidosis, 2016. Available: https:\/\/www.gov.uk\/drug-safety-update\/sglt2-inhibitors-updated-advice-on-the-risk-of-diabetic-ketoacidosis"},{"key":"2025082801214667000_15.9.e250233.7","doi-asserted-by":"crossref","first-page":"e22.1","DOI":"10.1016\/j.ajkd.2003.07.012","article-title":"Severe acidosis caused by starvation and stress","volume":"42","author":"Toth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2025082801214667000_15.9.e250233.8","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235953","article-title":"Case of sodium-glucose cotransporter-2 inhibitor-associated euglycaemic diabetic ketoacidosis","volume":"14","author":"Yeoh","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2025082801214667000_15.9.e250233.9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025590","article-title":"Postoperative extremity gangrene in a patient with type 2 diabetes taking SGLT2 inhibitors: a case report","volume":"100","author":"Wong","year":"2021","journal-title":"Medicine"},{"key":"2025082801214667000_15.9.e250233.10","doi-asserted-by":"crossref","first-page":"20:20","DOI":"10.1186\/s10195-019-0529-z","article-title":"Long-Term functional outcome after a low-energy hip fracture in elderly patients","volume":"20","author":"de Joode","year":"2019","journal-title":"J Orthop Traumatol"},{"key":"2025082801214667000_15.9.e250233.11","doi-asserted-by":"publisher","DOI":"10.1097\/BOT.0000000000001444"},{"key":"2025082801214667000_15.9.e250233.12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.7.766"},{"key":"2025082801214667000_15.9.e250233.13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1442-2018.2010.00535.x","article-title":"Determinants of ambulatory ability after hip fracture surgery in Japan and the USA","volume":"12","author":"Kondo","year":"2010","journal-title":"Nurs Health Sci"},{"key":"2025082801214667000_15.9.e250233.14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.5535\/arm.2014.38.6.827","article-title":"Prognostic factors predicting early recovery of Pre-fracture functional mobility in elderly patients with hip fracture","volume":"38","author":"Lee","year":"2014","journal-title":"Ann Rehabil Med"},{"key":"2025082801214667000_15.9.e250233.15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00198-009-0936-8","article-title":"A multicenter survey on profile of care for hip fracture: predictors of mortality and disability","volume":"21","author":"Maggi","year":"2010","journal-title":"Osteoporos Int"},{"key":"2025082801214667000_15.9.e250233.16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.injury.2011.03.021","article-title":"Diabetes mellitus and hip fracture: a study of 5966 cases","volume":"42","author":"Norris","year":"2011","journal-title":"Injury"},{"key":"2025082801214667000_15.9.e250233.17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1055\/s-0030-1270466","article-title":"Mortality after hip fracture in diabetic patients","volume":"119","author":"Gulcelik","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2025082801214667000_15.9.e250233.18","unstructured":"Centre for Perioperative Care . Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery, 2021"},{"key":"2025082801214667000_15.9.e250233.19","unstructured":"Scottish National Hip Fracture Steering Group . Scottish standards of care for hip fracture patients, 2019. Available: https:\/\/www.shfa.scot.nhs.uk\/_docs\/2020\/Scottish-standards-of-care-for-hip-fracture-patients-2020.pdf [Accessed 20 Feb 2022]."},{"key":"2025082801214667000_15.9.e250233.20","unstructured":"British Orthopaedic Association . The care of the older or frail orthopaedic trauma patient, 2019. Available: https:\/\/www.boa.ac.uk\/static\/a30f1f4c-210e-4ee2-98fd14a8a04093fe\/boast-frail-and-older-care-final.pdf"},{"key":"2025082801214667000_15.9.e250233.21","unstructured":"American Academy of Orthopaedic Surgeons . Management of hip fractures in older adults, 2021. Available: https:\/\/www.aaos.org\/globalassets\/quality-and-practice-resources\/hip-fractures-in-the-elderly\/hipfxcpg.pdf"},{"key":"2025082801214667000_15.9.e250233.22","unstructured":"National Institute for Health and Care Excellence . Hip fracture: management, 2011. Available: https:\/\/www.nice.org.uk\/guidance\/cg124\/resources\/hip-fracture-management-pdf-35109449902789"},{"key":"2025082801214667000_15.9.e250233.23","unstructured":"Public Health Scotland . Scottish hip fracture audit., 2020. Available: https:\/\/www.shfa.scot.nhs.uk\/Reports\/_docs\/2020-09-15-SHFA-Report.pdf"},{"key":"2025082801214667000_15.9.e250233.24","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afu036.48","article-title":"48 * delay or cancellation of surgery for hip fracture patients","volume":"43","author":"Chughtai","year":"2014","journal-title":"Age Ageing"},{"key":"2025082801214667000_15.9.e250233.25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-4-201108160-00006"},{"key":"2025082801214667000_15.9.e250233.26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.55095\/achot2021\/005","article-title":"Causes for delay to surgery in hip fractures and how it impacts on mortality: a single level 1 trauma center experience","volume":"88","author":"Kristan","year":"2021","journal-title":"Acta Chir Orthop Traumatol Cech"},{"key":"2025082801214667000_15.9.e250233.27","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1097\/BOT.0000000000000221","article-title":"Factors affecting delay to surgery and length of stay for patients with hip fracture","volume":"29","author":"Ricci","year":"2015","journal-title":"J Orthop Trauma"},{"key":"2025082801214667000_15.9.e250233.28","doi-asserted-by":"publisher","DOI":"10.1007\/BF03016088"},{"key":"2025082801214667000_15.9.e250233.29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32098-7","article-title":"Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis","volume":"8","author":"Klestil","year":"2018","journal-title":"Sci Rep"},{"key":"2025082801214667000_15.9.e250233.30","first-page":"S27","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16 Suppl 1","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"2025082801214667000_15.9.e250233.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2006.09.002"},{"key":"2025082801214667000_15.9.e250233.32","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.96B12.34378"},{"key":"2025082801214667000_15.9.e250233.33","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12244"},{"key":"2025082801214667000_15.9.e250233.34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00592-018-1116-0","article-title":"SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Puckrin","year":"2018","journal-title":"Acta Diabetol"},{"key":"2025082801214667000_15.9.e250233.35","unstructured":"Medicines and Healthcare products Regulatory Agency . SGLT2 inhibitors: reports of Fournier\u2019s gangrene (necrotising fasciitis of the genitalia or perineum), 2019. Available: https:\/\/www.gov.uk\/drug-safety-update\/sglt2-inhibitors-reports-of-fournier-s-gangrene-necrotising-fasciitis-of-the-genitalia-or-perineum"},{"key":"2025082801214667000_15.9.e250233.36","first-page":"26","article-title":"Sglt2 inhibitors and risk of genitourinary infections","volume":"27","author":"Chaplin","year":"2016","journal-title":"Prescriber"},{"key":"2025082801214667000_15.9.e250233.37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5435\/00124635-200001000-00007","article-title":"Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty","volume":"8","author":"David","year":"2000","journal-title":"Journal of the American Academy of Orthopaedic Surgeons"},{"key":"2025082801214667000_15.9.e250233.38","unstructured":"UK Clinical Pharmacy Association . UKCPA Handbook of perioperative medicines: sodium-glucose co-transporter-2 (SGLT-2) InhibitorsGLT-2 inhibitors (gliflozins). Available: https:\/\/www.ukcpa-periophandbook.co.uk\/medicine-monographs\/sodium-glucose-co-transporter-2-sglt-2-inhibitorsglt-2-inhibitors-gliflozins?c=diabetes [Accessed 21 Feb 2022]."},{"key":"2025082801214667000_15.9.e250233.39","unstructured":"U.S. Food and Drug Administration . FDA drug safety communication. Available: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-revises-labels-sglt2-inhibitors-diabetes-include-warnings-about-too-much-acid-blood-and-serious [Accessed 15 Jul 2022]."},{"key":"2025082801214667000_15.9.e250233.40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/bjh.14344","article-title":"Peri-Operative management of anticoagulation and antiplatelet therapy","volume":"175","author":"Keeling","year":"2016","journal-title":"Br J Haematol"},{"key":"2025082801214667000_15.9.e250233.41","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1210\/clinem\/dgac278","article-title":"Management of hyperglycemia in hospitalized adult patients in Non-Critical care settings: an endocrine Society clinical practice guideline","volume":"107","author":"Korytkowski","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-250233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:21:56Z","timestamp":1756369316000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-250233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,16]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bcr-2022-250233"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-250233","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}